Metoprolol Succinate Extended-release Tablets — Class II drug recall D-0009-2015
Terminated recall by Mylan Pharmaceuticals Inc., reported 2014-10-15, distributed nationwide. Presence of Foreign Tablets/Capsules: A pharmacist reported a rogue tablet of different size and markings in b
| Recall number | D-0009-2015 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Mylan Pharmaceuticals Inc., Morgantown, WV, United States |
| Recall initiated | 2014-07-03 |
| Classified | 2014-10-08 |
| Reported by FDA | 2014-10-15 |
| Terminated | 2016-09-20 |
| Distributed | Nationwide (US) |
| Quantity | 15,966 bottles |
| NDC | 00378-4596-77 |
| Lot numbers | 11/15, 3023805 |
Product
Metoprolol Succinate Extended-release Tablets, USP 50mg, 90-count Bottles, Rx only, Mfg by Mylan Pharmaceuticals, Inc. Morgantown, WV 26505. NDC 0378-4596-77.
Reason for recall
Presence of Foreign Tablets/Capsules: A pharmacist reported a rogue tablet of different size and markings in bottle of Metoprolol
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0009-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.